Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Re-evaluating Drug Data Generated By Fraudulent Clinical Investigator

Executive Summary

FDA is reviewing data related to drug studies conducted by clinical investigator Robert Fiddes, MD, to ensure the safety and effectiveness of products for which he falsified clinical trial data.

You may also be interested in...



FDA's Data Falsification Proposed Rule Is Overly Strict, Sponsors Say

Agency needs to better define the evidence threshold for reporting suspected clinical trial fraud to the agency, industry commenters say.

Manufacturers Should Oversee CROs, Investigators – U.S. Prosecutor Sheehan

Pharmaceutical manufacturers will be held liable for the conduct of contract research organizations and principal investigators, Assistant U.S. Attorney Jim Sheehan said

Manufacturers Should Oversee CROs, Investigators – U.S. Prosecutor Sheehan

Pharmaceutical manufacturers will be held liable for the conduct of contract research organizations and principal investigators, Assistant U.S. Attorney Jim Sheehan said

Related Content

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel